ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
NervGen Pharma Corporation (QB)

NervGen Pharma Corporation (QB) (NGENF)

2.16
0.01
(0.47%)
Closed 30 April 6:00AM

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2024 2018201920202021202220232024
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 3.1M6.77M6.68M17.9M23.88M13.24M19.49M
Total Current Assets 2.55M6.26M6.2M17.42M23.15M12.52M19.01M
Cash and Equivalents 2.47M4.11M5.6M16.93M22.45M11.66M17.27M
Total Non-Current Assets 2.51M5.84M5.92M16.82M13.46M-2.01M2.58M
Total Liabilities 583k924k755k1.08M10.41M15.25M16.91M
Total Current Liabilities 449k924k755k1.08M10.22M15.14M16.9M
Total Non-Current Liabilities 134k000197k105k8k
Total Equity 2.51M5.84M5.92M16.82M13.46M-2.01M2.58M
Common Equity 3.85M15.29M22.95M42.4M57.41M58.93M81.1M
Retained Earnings -1.37M-11.14M-22.32M-35.05M-55.77M-78.15M-102.16M